Clinical trials / NCT04917874
NCT04917874Phase 3Completed

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Study sponsor: Krystal Biotech, Inc. · KRYS

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2023-07-31Actual
Enrollment · participants47Actual
Source updated2024-04-09Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.